ENTPD1 and cancer: As supported in another high-dimensional profiling study of CD4+ TILs in human cancer tissues, CD39 expression could be used to distinguish tumor-specific CD4+ T cells from diverse CD4+ TILs (e.g., regulatory T cells and bystander CD4+ T cells) (40).